GLP-1 medication guide
Mounjaro
Mounjaro is a brand-name tirzepatide medication used in type 2 diabetes care. Patients also recognize the name when researching GIP and GLP-1 medications, appetite, and medical weight-management options.
Overview
What Mounjaro is
Mounjaro contains tirzepatide and works with the GIP and GLP-1 pathways involved in blood-sugar regulation, appetite, and digestion. It is used as part of type 2 diabetes care.
Potential benefits and patient goals
- Understanding Mounjaro and tirzepatide
- Blood-sugar and metabolic-health questions
- How GIP and GLP-1 medications relate to weight goals
Your next step
Build a plan around your goals
A free virtual consultation gives you a direct way to connect your goals with the potential benefits of Mounjaro, ask questions, and explore a personalized next step. If an in-person examination or testing would strengthen the plan, the care team will make that process clear.
Begin with a free virtual consultation to discuss Mounjaro, tirzepatide, your goals, and the care options that may fit your needs.
Book a free virtual consultationRelated care
Explore more treatment options
Questions
Common questions about Mounjaro
What is Mounjaro?
Mounjaro is a brand-name prescription medication containing tirzepatide and used in type 2 diabetes care.
How is Mounjaro related to Zepbound?
Both contain tirzepatide, but they are separate products used for different clinical goals.
Why do patients ask about Mounjaro during weight-management visits?
Many people recognize Mounjaro when researching GIP and GLP-1 medications and want to understand how tirzepatide relates to appetite and weight goals.
Can I start with a free virtual consultation?
Yes. The consultation can cover your goals, health history, previous approaches, and questions about Mounjaro and tirzepatide.
Ready to explore your options?
Take the next step toward your goals
Meet with the Florida Regenerative care team to explore potential benefits, compare treatment options, and build a plan around what you want to improve.